HOME >> MEDICINE >> NEWS
Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Houston May 08, 2007 -- A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.

"Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors," says review author Dr. Siqing Fu, an assistant professor of oncology at the University of Texas at Houston. "However, more research is needed to determine whether combining molecular-targeted therapy with hormonal therapy would be a more effective option."

Ovarian cancer is the deadliest of gynecological cancers; approximately 70 percent of patients are diagnosed in the later stages, when the 5-year survival rate drops below 25 percent. Traditional chemotherapy has proven to be generally ineffective against recurrent ovarian cancer, which has led researchers to investigate novel treatments.

"While a cure is unlikely, the goals of treatment are to control tumor-related symptoms and to improve or maintain quality of life," says Dr. Fu. "After surveying the latest research, combined molecular-targeted and hormonal therapy offers the greatest promise in achieving these goals and therefore deserves further investigation."


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-May-2007


Page: 1

Related medicine news :

1. Combined imaging approach may provide better identification of difficult-to-diagnose brain clots
2. Combined therapies may boost immune response and long-term protection against brain tumors
3. Combined liver-kidney transplant beneficial for patients with dual organ disease
4. Combined contrast enhanced MRI shows promise
5. Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
6. Combined MRI and mammography more effective at detecting breast cancer in high-risk women
7. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
8. Bulimia may result from hormonal imbalance
9. 1 in 5 early-stage breast cancer patients may not follow hormonal therapy plan
10. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
11. Some nonhormonal therapies may offer relief from hot flashes, but with possible adverse effects

Post Your Comments:
(Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
(Date:3/3/2015)... March 03, 2015 All ... website that focuses on providing an interactive directory ... and addiction treatment for clients ranging in ages ... on the site have a wide variety of ... disorders, severe learning disabilities, drug rehabilitation, failure to ...
(Date:3/2/2015)... Getting customers to discover a whole new world ... as the 31st annual Frozen Food Month kicks off. ... Refrigerated Foods Association (NFRA) to stimulate the awareness and ... delicious frozen selections and is thrilled to be part ... are crafted with simple ingredients, no preservatives or artificial ...
(Date:3/2/2015)... 02, 2015 Today the Brain Injury Association ... a time to recognize and support the more than 5.3 ... Each year BIAA leads the nation in observing Brain Injury ... of March. The theme for the 2015 to 2017 campaign ... a platform for educating the general public about the incidence ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to offer ... Analysts Inc and recently added to its catalogue. , ... 2018, the global radiation therapy equipment market is poised ... suggests a holistic analysis of the situation in the ... covers the top market trends. The publication uncovers data ...
Breaking Medicine News(10 mins):Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3
(Date:3/2/2015)... LAKES, N.J. , March 2, 2015 ... ), a leading global medical technology company, today announced ... San Diego -based medical technology company dedicated to ... The acquisition furthers BD,s position in helping address preventable ... BD and CRISI entered into an exclusive partnership in ...
(Date:3/2/2015)... 2015  Vivex Biomedical, Inc., a leading processor of ... announced today that it hired Lou Barnes ... Inc.   Vivex Biomedical formed UMTB Biomedical as a wholly-owned ... (UMTB) in November 2014. UMTB is the oldest tissue ... a twenty-five year veteran of the tissue banking industry, ...
(Date:3/2/2015)... CORTLANDT MANOR, N.Y. , March 2, 2015 /PRNewswire/ ... patients screened for CRC.   During CRC Awareness Month, we ... items throughout March. , Posters – ... seating areas , CRC Patient Brochures with Stand ... , Screening Reminder Post-its – to be put on/in ...
Breaking Medicine Technology:BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2
Cached News: